The Effect of Intermittent Fasting on Glucose and Lipid Disorder among patients of Diabetes Mellitus Type-2
DOI:
https://doi.org/10.53350/pjmhs221674Keywords:
Intermittent Fasting, Diabetes mellitus, weight loss, Lipid DisorderAbstract
Background: The diabetes Mellitus Type -2 disease has become prevalent globally and the treatment of the disease is quite expansive and long term, especially in the low-income countries like Pakistan.
Aim: To explore the evidence of the efficacy of Intermittent Fasting as an alternative therapy in Diabetes Mellitus Type-2 by reviewing the existing literature on intermittent fasting globally.
Methods: The literature on the effect of Intermittent Fasting on diabetes type-2 was searched on PubMed, and Google scholar and more than 20 studies conducted on the IF on human beings were identified at national, regional, and global levels and reviewed.
Results: Not much literature is available on Intermittent Fasting, especially in low-income countries and the majority of the studies have been conducted in high-income countries like the USA, Canada, Australia, and the UK. A few long-term, Randomized Control Trials have been conducted, and most are short-term studies. A few studies have been found on Diabetes Mellitus Type-2 in India and Pakistan that too related to the prevalence and economic burden of the disease in these countries.
Conclusion: Based on the studies reviewed, we can conclude that there is growing evidence demonstrating the benefits of Intermittent Fasting in short- and medium-term studies on glucose and lipid homeostasis but there is a need to carry out more long-term studies with a larger number of participants and in low-income countries. Furthermore, the existing literature reveals that Intermittent Fasting can be used as an alternative in the supervision of physicians otherwise can be counterproductive.
Downloads
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.